Company news

Yoda Pharmaceuticals Inc. news

Latest news releases, newest first.

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

July 28, 2026